Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Proponents often stress the opportunity for substantial therapeutic gains, particularly in diseases where conventional treatments have proven limited. However, it's to evaluate the considerable financial burden associated with CPI stem cell therapy,